Dark Circles Under the Eyes: The Four Causes and Why Each One Needs a Different Fix

Most patients who come in for a dark-circle consultation have already tried three or four products that changed nothing. That is not a failure of effort. Dark circles are four anatomically distinct problems that share a single visual symptom, and a product or procedure aimed at the wrong mechanism will not work no matter how consistently it is applied. Before any treatment decision makes sense, the type has to be identified first.

Why Dark Circles Are Not a Single Diagnosis

The formal clinical classification divides periorbital darkening into four subtypes: Pigmented (P), Vascular (V), Structural (S), and Mixed (M). Each originates in different tissue, looks different on examination, and requires a different primary treatment. Using a laser on a structural shadow, or placing filler in a vascular dark circle, does not just miss the target - it can actively worsen the problem. This is not a theoretical concern. It is the predictable result of mismatched treatment, and it happens regularly because the category distinction is rarely communicated to patients before they begin.

A 2025 systematic review and meta-analysis published in Dermatologic Therapy (Wiley) found that 82% of dark-circle patients have a predominantly vascular component and 54% have pigment deposition. Because both figures exceed 50%, the majority of patients are carrying more than one cause at once. That overlap is precisely why a classification framework matters - not as academic labeling, but as a targeting system for deciding what to treat, in what order, and with what tool.

The Anatomy That Makes All Four Types Possible

The lower eyelid is an anatomically exposed surface. The skin there is the thinnest on the entire body - roughly one quarter the thickness of cheek skin - which is why everything beneath it registers at the surface. A dense venous network runs just below this skin; when blood is deoxygenated or the vessels are dilated, a blue-purple tint transmits directly through. Melanin in the skin layers adds brown or grey discoloration from above. Deeper still, the orbital fat pads are contained by the arcus marginalis, the periosteal attachment where the lower orbital rim meets the cheek. When fat thins with age and the supporting bone recedes, the nasojugal groove deepens into a concavity that overhead light cannot reach. The eye interprets that shadow as dark circles even when the skin itself carries no pigmentation abnormality at all.

One additional structure is frequently missed in this discussion: the orbicularis oculi muscle. A visible crescent of muscle just below the lower lash line can cast its own independent shadow, entirely separate from fat herniation or hollowing, and it requires a different assessment and a different treatment than either of those conditions. Overlooking it leads to procedures that address the wrong anatomy.

Pigmented Type: Two Depths, Two Different Problems

Pigmented dark circles appear brown in ordinary light, and the discoloration moves visibly with the skin when it is gently lifted. Melanin is the cause, but the depth at which that melanin sits determines whether standard treatments can reach it.

Epidermal Versus Dermal Melanin

Epidermal melanin occupies the outer skin layers. It responds to topical agents - hydroquinone, kojic acid, retinoids, azelaic acid - and to superficial chemical peels that increase cell turnover. Dermal melanin is a different problem entirely. Deposited deeper in the skin after chronic UV exposure or repeated inflammatory episodes, it appears grey-brown rather than warm brown. Topical agents cannot reach it in any therapeutically meaningful concentration. Dermal pigment typically requires a Q-switched Nd:YAG laser, which selectively targets melanin, and even then correction is gradual and requires multiple sessions.

The distinction between the two is made in the clinic with a Wood's lamp. Under UV illumination, epidermal melanin accentuates visibly. Dermal melanin does not. That single step - which takes roughly thirty seconds - changes the entire treatment plan. Skipping it means choosing between two options with different mechanisms, different risk profiles, and very different outcomes without any basis for the choice.

Laser Safety and Skin Tone in South Florida

Periorbital hyperpigmentation is substantially more prevalent in Fitzpatrick skin types III through VI, the deeper complexions that make up a large portion of South Florida's patient population. The risk of aggressive laser treatment in these patients is post-inflammatory hyperpigmentation: the treatment provokes a skin response that deposits additional melanin and darkens the area further than it was before. Conservative fluence settings, extended intervals between sessions, and thorough pre-treatment skin-type assessment are requirements in this population, not optional precautions.

For patients who cannot receive laser safely - because of skin type, active photosensitivity, or other contraindications - a split-site clinical trial evaluated tranexamic acid combined with vitamin C delivered by mesotherapy. That combination showed measurable pigment reduction for the pigmented subtype, offering a non-laser injectable pathway when laser carries too much risk.

Vascular Type: When the Problem Is in the Blood

Vascular dark circles look blue or purple and are typically most noticeable in the morning, after overnight pooling of venous blood. The color comes from deoxygenated blood in the dermal venous plexus showing through the translucent lower-eyelid skin. No brightening cream addresses that because the problem is not in the melanocytes.

PDL and Carboxytherapy

Pulsed dye laser targets oxyhemoglobin in dermal capillaries, making it the correct laser choice for the vascular type. Q-switched Nd:YAG, calibrated for melanin, is not the right instrument here. Using the wrong wavelength produces minimal improvement while risking post-inflammatory pigmentation - a compounding problem in patients who may already carry a mixed-type pigment component.

Carboxytherapy provides a different mechanism. Subcutaneous injection of medical-grade carbon dioxide displaces oxygen-depleted blood, improves local microcirculation, and over time stimulates collagen production in the overlying skin. Studies document measurable lightening of the vascular subtype with minimal downtime. It is a practical option for patients who prefer to avoid laser, who have skin-type contraindications to PDL, or who want to address both the venous congestion and the skin thinning that makes it visible.

Structural Type: The Shadow Problem

Structural dark circles are not discoloration. They are shadows created by the three-dimensional shape of the periorbital region. The skin may be entirely normal. The topography beneath it is not.

The Arcus Marginalis and the Deepening Groove

The arcus marginalis holds orbital fat against the orbital rim. As fat volume decreases with age and the bony architecture of the midface recedes, the nasojugal groove deepens into a concavity that overhead light cannot reach. That shadow reads as darkness. In other patients the problem runs in the opposite direction: fat herniates forward through the arcus marginalis, creating a lower-lid bulge that pushes the skin outward and makes the shadowed groove below it appear more severe by contrast. Both mechanisms produce structural dark circles, but they represent opposite anatomic states that call for different responses.

Filler, Fat Grafting, and Blepharoplasty: What Each Actually Does

The 2025 Dermatologic Therapy systematic review identifies soft tissue fillers and autologous fat grafting as the most effective interventions for volume-loss dark circles. Hyaluronic acid filler in the tear trough corrects structural shadowing immediately by filling the hollow, and it suits patients whose problem is purely volume loss with no significant skin laxity or fat herniation. The volume placed is typically small - well under 1 mL per side - but the effect on shadow depth can be substantial.

The critical distinction is this: filler is camouflage, not correction. When fat herniation and skin laxity are both contributing to the structural problem, lower blepharoplasty with fat repositioning is the definitive treatment. Fat is moved from where it has herniated and placed into the tear trough from behind the muscle, correcting the anatomy from the inside. Filler used as a bridge in this scenario may need to be dissolved before surgery to allow accurate tissue assessment and clean planes of dissection. Patients who anticipate blepharoplasty should discuss that timing with their surgeon before beginning filler, not after.

The Orbicularis Roll: A Distinct Source of Shadow

Just below the lower lash line, the orbicularis oculi muscle can form a visible crescent - a roll or ridge of muscle fullness - that casts its own shadow independent of orbital fat herniation or tear trough hollowing. This structure is regularly misidentified as a fat bag, and the misidentification leads directly to the wrong treatment.

• An orbicularis roll is a firm, crescent-shaped fullness immediately below the lashes, not in the mid-lower lid where the orbital fat compartments sit
• It becomes more pronounced with animation - squinting or smiling - because the muscle is actively contracting, distinguishing it from herniated fat that changes little with expression
• It does not transilluminate or shift with gentle pressure the way fat pads do
• Injecting filler below a prominent orbicularis roll adds projection beneath it and deepens the shadow it casts rather than softening it

Recognizing the orbicularis roll as a distinct anatomic structure requires a dynamic examination - watching the lower lid during expression and comparing it at rest - not just a static view with the face neutral. Patients who have had repeat tear trough filler with progressive worsening of the lower-lid shadow should ask specifically whether the orbicularis roll was assessed separately from the hollowing.

Mixed Type: Why the Order of Procedures Matters

Most patients in practice have more than one cause operating simultaneously - the vascular and pigmented overlap is extensively documented. Treatment has to be planned as a sequence, not a simultaneous combination. The order matters for safety and for the accuracy of each subsequent step.

Platelet-rich plasma injected in the periorbital region addresses the skin quality that makes vascular and pigmented components more visible. PRP improves skin thickness and collagen density gradually over several months following injection, and a single treatment session can sustain those changes for many months. It does not correct structural hollowing and does not replace targeted laser or vascular treatment, but for patients whose thin, translucent skin is amplifying every underlying component, it is a logical adjunct before or alongside the more targeted work.

For mixed-type patients, a rational treatment sequence follows this order:

1. Complete the full physical examination - including all three bedside tests - before any procedure is scheduled, to map all components and their relative severity
2. Address the vascular component first when significant, because active venous congestion alters how overlying pigmentation appears and can obscure accurate assessment of what remains
3. Treat pigmentation next, working from epidermal to dermal as the Wood's lamp examination indicates, starting at conservative settings to avoid triggering post-inflammatory hyperpigmentation in the post-vascular-treatment skin
4. Treat structural hollowing last - after the skin changes from prior steps have stabilized - so the remaining shadow can be judged without the visual amplification that congested, hyperpigmented skin creates
5. Reassess between stages rather than proceeding on the original plan unchanged, since correcting one component routinely reduces the apparent severity of the others and the total volume or energy needed drops accordingly

Treating all components in the same session is a common error. Filler placed before vascular treatment can obscure venous anatomy for the PDL operator. Aggressive laser before the venous component is cleared raises the risk of post-inflammatory pigmentation in congested tissue. And structural filler placed while pigmentation is still active tends to be over-placed, because the remaining shadow appears larger than the structural anatomy alone would produce.

The Bedside Self-Exam: Three Tests Before Your Consultation

Three simple tests can help identify which component is most prominent before you meet with a surgeon. They do not replace clinical assessment, but they give you accurate descriptive language for the consultation and help you ask sharper questions about what is being proposed and why.

The pinch test targets pigmentation. Gently pinch the skin of the lower eyelid between two fingers and lift it slightly away from the underlying tissue. If the darkness is still clearly visible in the elevated pinch, the discoloration lives in the skin itself - a positive sign for the pigmented type.

The stretch test targets the vascular type. Place two fingers on the lower-lid skin and pull gently downward toward the cheek, stretching it taut. If the darkness turns distinctly blue or purple under that stretch, venous blood in the underlying plexus is a primary source.

The shadow test targets the structural type. Tilt your chin toward a strong overhead light source and watch the lower lid. If the darkness disappears completely when the groove fills with direct overhead light, it is a shadow - not pigmentation, not venous blood - and the structural type is dominant.

• If the darkness partly lifts on the pinch test but does not change at all on the shadow test, a mixed pigmented and vascular picture is likely
• If the shadow test eliminates most of the darkness but a residual blue-grey tint persists, both the structural and vascular components are active
• If none of the three tests produce a clear response, a Wood's lamp examination in a clinical setting is the most informative next step

When Surgery Is the Only Real Answer

The clinical signs that indicate lower blepharoplasty over injectables are specific and identifiable. The 2025 systematic review is direct on this: blepharoplasty is the definitive option when skin laxity is the primary structural driver. Filler in those cases is camouflage applied over a problem that camouflage cannot correct.

• Visible fat herniation producing a lower-lid bulge that is present at rest and increases with upward gaze - filler below a herniated pad adds projection without addressing the prolapse that creates the shadow
• Redundant lower-lid skin with a textural irregularity that the shadow test confirms is structural - skin laxity cannot be filled away
• Prior filler that has produced a progressively puffy or overfull lower lid, signaling that the anatomy requires correction rather than additional volume
• A tear trough deformity severe enough that the volume needed to fill it would produce an unnatural convexity before the shadow is eliminated
• A pattern of repeat filler treatments with progressively shorter intervals between them - the anatomy is changing faster than the camouflage can track it

Soft tissue fillers and autologous fat grafting are the most effective interventions for volume-loss dark circles, while blepharoplasty remains the definitive option when skin laxity is the primary driver.Dermatologic Therapy, 2025 systematic review and meta-analysis

Lower blepharoplasty with fat repositioning moves herniated fat into the tear trough from behind the orbicularis muscle rather than layering filler over it from outside. The anatomy is corrected, not covered. For patients with strongly positive shadow tests, visible fat herniation, and a history of diminishing returns from repeat filler, surgery is not the aggressive option - it is the accurate one. An oculoplastic surgeon can distinguish these findings clearly during a consultation and explain which anatomy is actually driving the problem.

Frequently Asked Questions

Can dark circles be permanently eliminated?

That depends entirely on the type. Structural dark circles corrected with blepharoplasty and fat repositioning produce long-lasting results because the underlying anatomy is changed. Pigmented dark circles can recur with unprotected sun exposure. Vascular dark circles often require ongoing maintenance treatment because the vessel anatomy that produces them does not change permanently after PDL or carboxytherapy.

Why are my dark circles worst in the morning and better by midday?

Morning worsening is a reliable indicator of a vascular component. Venous blood pools in the periorbital tissue overnight when the head is horizontal, and the blue-purple hue is most intense before daytime circulation clears the deoxygenated blood. If the darkness is noticeably lighter by early afternoon, the vascular type is likely the dominant mechanism in your case.

Can eye cream actually treat dark circles, or is it a waste of money?

Eye creams containing retinoids, vitamin C, or hydroquinone can genuinely improve epidermal pigmentation over several months of consistent use. They have no effect on dermal pigment, venous congestion, or structural shadowing - which together account for a large share of dark-circle complaints in most patient populations. If a topical product has produced no visible change after three to four months of daily use, the active mechanism is probably not epidermal melanin.

Why did filler make my dark circles look worse?

Two mechanisms explain most filler-worsening cases. First, filler placed over a vascular dark circle creates a Tyndall effect - a visible blue cast from light scattering through the gel in thin-skinned tissue - that compounds the existing venous hue. Second, filler placed below a herniated fat pad adds projection beneath the bulge and deepens the shadow beneath it rather than filling it. Both outcomes follow directly from placing filler without first identifying the type.

What is carboxytherapy, and how does it compare to laser for dark circles?

Carboxytherapy involves injecting small amounts of medical-grade carbon dioxide gas subcutaneously into the periorbital area. The CO2 displaces pooled, deoxygenated blood, improves microcirculation, and stimulates gradual collagen production. Studies show measurable improvement specifically in the vascular subtype, and downtime is minimal. Unlike PDL, it does not target oxyhemoglobin directly - it works through circulation and skin quality - making it a complementary option rather than a strict replacement for laser in most vascular cases.

How do I know whether I need surgery or just filler for my structural dark circles?

The clearest indicators for surgery are visible fat herniation creating a lower-lid bulge, meaningful skin laxity, and a history of filler that worked well initially but has needed increasing volume or shorter intervals to maintain the result. If your shadow test is strongly positive and you have a visible ridge in the lower lid when looking upward or squinting, blepharoplasty is likely to produce a more durable and anatomically accurate correction than continued filler. An oculoplastic surgeon evaluating these specific findings can differentiate the two paths clearly during a consultation.